Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorChemical name: Fmoc-Lys(tBu-OOC-C16-CO-Glu(AEEA-AEEA)-OtBu)-OH // Synonyms: (23S,50S)-50-(((9H-fluoren-9-yl)methoxy)carbonylamino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oicacid, Semaglutide- Linker, Fmoc-Lys(Ggu-L-Glu(AA-AA)-OH
from €390.00
Dipeptide building block for SPPS synthesis of Semaglutide (brand name Ozempic). Semaglutide is a GLP-1 analogue and has been developed in 2012 by Novo Nordisk SA for the treatment of diabetes type 2 as a longer-acting alternative to liraglutide. It was found in 2017 that it also can be used for the treatment of obesity.
"Abstracts of the 48th EASD Annual Meeting of the European Association for the Study of Diabetes". Diabetologia 2012; 55(1): 1–538. DOI: 10.1007/s00125-012-2688-9.
Please send me more information about